Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy.

by Alessandra Bandera, Alessandra Bandera, Andrea Gori, Francesca Sabbatini, Giordano Madeddu, Stefano Bonora, Raffaella Libertone, Claudio Mastroianni, Paolo Bonfanti, Antonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Icona Foundation Study Group
Published 2015-01-01

Proportion and factors associated with recent HIV infection in a cohort of patients seen for care in Italy over 1996-2014: Data from the ICONA Foundation Study cohort.

by Silvia Nozza, Alessandro Cozzi-Lepri, Francesca Bai, Stefano Rusconi, Andrea Gori, Paola Cinque, Adriana Ammassari, Pietro Caramello, Giuseppe Tambussi, Antonella D'Arminio Monforte, Giulia Marchetti, Icona Foundation Study Group
Published 2017-01-01

Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: an observational cohort study

by Cristina Mussini, Patrizia Lorenzini, Alessandro Cozzi-Lepri, Giulia Marchetti, Stefano Rusconi, Andrea Gori, Silvia Nozza, Miriam Lichtner, Andrea Antinori, Andrea Cossarizza, Antonella d’Arminio Monforte, for the Icona Foundation Study Group
Published 2018-05-01

Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

by Milensu Shanyinde, Enrico Girardi, Massimo Puoti, Andrea De Luca, Laura Sighinolfi, Uberti Foppa Caterina, Pietro Caramello, Fiona C. Lampe, Antonella D’Arminio Monforte, Alessandro Cozzi-Lepri, for the ICONA Foundation Study Group
Published 2019-10-01

Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy

by Annalisa Saracino, Mauro Zaccarelli, Patrizia Lorenzini, Alessandra Bandera, Giulia Marchetti, Francesco Castelli, Andrea Gori, Enrico Girardi, Cristina Mussini, Paolo Bonfanti, Adriana Ammassari, Antonella d’Arminio Monforte, for the Icona Foundation Study Group
Published 2018-07-01

Response to First-Line Ritonavir-Boosted Protease Inhibitors (PI/r)-Based Regimens in HIV Positive Patients Presenting to Care with Low CD4 Counts: Data from the Icona Foundation C...

by Antonella d'Arminio Monforte, Alessandro Cozzi-Lepri, Franco Maggiolo, Giuliano Rizzardini, Paolo Emilio Manconi, Nicola Gianotti, Tiziana Quirino, Carmela Pinnetti, Stefano Rusconi, Andrea De Luca, Andrea Antinori, Icona Foundation Study cohort
Published 2016-01-01

Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus.

by Cristina Mussini, Patrizia Lorenzini, Massimo Puoti, Miriam Lichtner, Giuseppe Lapadula, Simona Di Giambenedetto, Andrea Antinori, Giordano Madeddu, Alessandro Cozzi-Lepri, Antonella d'Arminio Monforte, Andrea De Luca, ICONA Foundation Study Group
Published 2015-01-01

Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008–2018 in Italy

by Silvia Nozza, Laura Timelli, Annalisa Saracino, Nicola Gianotti, Claudia Lazzaretti, Alessandro Tavelli, Massimo Puoti, Sergio Lo Caputo, Andrea Antinori, Antonella d’Arminio Monforte, Cristina Mussini, Enrico Girardi, on behalf of ICONA Foundation Study Group
Published 2021-07-01

HIV-1 co-receptor tropism and liver fibrosis in HIV-infected patients.

by Annalisa Saracino, Alessandro Cozzi-Lepri, Milensu Shanyinde, Francesca Ceccherini Silberstein, Silvia Nozza, Antonio Di Biagio, Giovanni Cassola, Giuseppe Bruno, Maria Capobianchi, Massimo Puoti, Laura Monno, Antonella d'Arminio Monforte, ICONA Foundation Study
Published 2018-01-01

Long-Term Durability of Tenofovir-Based Antiretroviral Therapy in Relation to the Co-Administration of Other Drug Classes in Routine Clinical Practice.

by Silvia Costarelli, Alessandro Cozzi-Lepri, Giuseppe Lapadula, Stefano Bonora, Giordano Madeddu, Franco Maggiolo, Andrea Antinori, Massimo Galli, Giovanni Di Perri, Pierluigi Viale, Antonella d'Arminio Monforte, Andrea Gori, ICONA Foundation Study Group
Published 2016-01-01

Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.

by Antonella Cingolani, Alessandro Cozzi Lepri, Luciana Teofili, Laura Galli, Valentina Mazzotta, Gian Maria Baldin, Stefan Hohaus, Alessandra Bandera, Lucia Alba, Nadia Galizzi, Antonella Castagna, Antonella D'arminio Monforte, Andrea Antinori, ICONA Foundation Study group
Published 2017-01-01

Evaluation of HIV Transmission Clusters Among Natives and Foreigners Living in Italy

by Lavinia Fabeni, Maria Mercedes Santoro, Patrizia Lorenzini, Stefano Rusconi, Nicola Gianotti, Andrea Costantini, Loredana Sarmati, Andrea Antinori, Francesca Ceccherini-Silberstein, Antonella d’Arminio d’Arminio Monforte, Annalisa Saracino, Enrico Girardi, on behalf of the Icona Foundation Study Cohort
Published 2020-07-01

Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort.

by Antonella Cingolani, Alessandro Cozzi-Lepri, Adriana Ammassari, Cristina Mussini, Maria Alessandra Ursitti, Pietro Caramello, Gioacchino Angarano, Paolo Bonfanti, Andrea De Luca, Maria Stella Mura, Enrico Girardi, Andrea Antinori, Antonela D'Arminio Monforte, Icona Foundation Study group
Published 2014-01-01

Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients.

by Nicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, Antonella Castagna, Andrea De Luca, Benedetto Maurizio Celesia, Massimo Galli, Cristina Mussini, Carmela Pinnetti, Vincenzo Spagnuolo, Antonella d'Arminio Monforte, Francesca Ceccherini-Silberstein, Massimo Andreoni, Icona Foundation Study and mono-PI/r database Study Cohorts
Published 2017-01-01